These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 19068687)

  • 1. [Economic impact of overactive bladder symptoms in Japan].
    Inoue S; Kobayashi M; Sugaya K
    Nihon Hinyokika Gakkai Zasshi; 2008 Nov; 99(7):713-22. PubMed ID: 19068687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of New Medications and $4 Generic Programs on Overactive Bladder Treatment Among Older Adults in the United States, 2000-2015.
    Kinlaw AC; Jonsson Funk M; Conover MM; Pate V; Markland AD; Wu JM
    Med Care; 2018 Feb; 56(2):162-170. PubMed ID: 29287033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of illness of the cervical cancer of the uterus in Japan--a time trend and future projections.
    Hayata E; Seto K; Haga K; Kitazawa T; Matsumoto K; Morita M; Hasegawa T
    BMC Health Serv Res; 2015 Mar; 15():104. PubMed ID: 25886141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic burden of COVID-19, China, January-March, 2020: a cost-of-illness study.
    Jin H; Wang H; Li X; Zheng W; Ye S; Zhang S; Zhou J; Pennington M
    Bull World Health Organ; 2021 Feb; 99(2):112-124. PubMed ID: 33551505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D supplements and prevalent overactive bladder in women from midlife through older ages.
    Vaughan CP; Markland AD; Huang AJ; Tangpricha V; Grodstein F
    Menopause; 2022 Dec; 29(12):1399-1403. PubMed ID: 36166726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic burden of alopecia areata: A study of direct and indirect cost in Japan using real-world data.
    Ohyama M; Kamei K; Yuasa A; Anderson P; Milligan G; Sakaki-Yumoto M
    J Dermatol; 2023 Oct; 50(10):1246-1254. PubMed ID: 37435720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of illness of ischemic heart disease in Japan: a time trend and future projections.
    Gochi T; Matsumoto K; Amin R; Kitazawa T; Seto K; Hasegawa T
    Environ Health Prev Med; 2018 May; 23(1):21. PubMed ID: 29793437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review and meta-analysis of urinary incontinence prevalence and population estimates.
    Sadri H; Oliaei A; Sadri S; Pezeshki P; Chughtai B; Elterman D
    Neurourol Urodyn; 2024 Jan; 43(1):52-62. PubMed ID: 37661792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and impact on daily life of lower urinary tract symptoms in Japan: Results of the 2023 Japan Community Health Survey (JaCS 2023).
    Mitsui T; Sekido N; Masumori N; Haga N; Omae K; Saito M; Kubota Y; Sakakibara R; Yoshida M; Takahashi S
    Int J Urol; 2024 Jul; 31(7):747-754. PubMed ID: 38514235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxybutynin topical gel in the treatment of overactive bladder.
    Davila GW
    Open Access J Urol; 2010 Jun; 2():91-8. PubMed ID: 24198618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost of illness of breast cancer in Japan: trends and future projections.
    Matsumoto K; Haga K; Kitazawa T; Seto K; Fujita S; Hasegawa T
    BMC Res Notes; 2015 Oct; 8():539. PubMed ID: 26438238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of overactive bladder.
    Nitti VW
    Rev Urol; 2002; 4 Suppl 4(Suppl 4):S2-6. PubMed ID: 16986018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the economic burden of stroke in China: a cost-of-illness study.
    Ma J; Tian Z; Chai P; Wan Q; Zhai T; Guo F; Li Y
    BMJ Open; 2024 Mar; 14(3):e080634. PubMed ID: 38485178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs of psychotropics for outpatients with bipolar disorder in Japan; the MUSUBI 2016 survey.
    Adachi N; Kubota Y; Goto E; Watanabe K; Yoshimura R; Tsuboi T; Yasui-Furukori N; Kato M; Hongo S; Azekawa T; Katsumoto E; Edagawa K; Nakagawa A; Kikuchi T; Ueda H; Miki K
    Ann Med; 2023 Dec; 55(1):2224047. PubMed ID: 37322994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in dental expenditures in Japan with a universal health insurance system.
    Sato Y; Fukai K; Kunori Y; Yoshioka E; Saijo Y
    PLoS One; 2023; 18(10):e0292547. PubMed ID: 37796959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economic and social costs of body dissatisfaction and appearance-based discrimination in the United States.
    Yetsenga R; Banerjee R; Streatfeild J; McGregor K; Austin SB; Lim BWX; Diedrichs PC; Greaves K; Mattei J; Puhl RM; Slaughter-Acey JC; Solanke I; Sonneville KR; Velasquez K; Cheung S
    Eat Disord; 2024 Mar; ():1-31. PubMed ID: 38520696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost of illness for colorectal cancer in Japan - a time trend and future projections (1996-2035) based on governmental statistics.
    Matsumoto K; Hatakeyama Y; Seto K; Onishi R; Hirata K; Wu Y; Hasegawa T
    BMC Health Serv Res; 2023 Aug; 23(1):888. PubMed ID: 37608367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription of anti-influenza drugs in Japan, 2014-2020: A retrospective study using open data from the national claims database.
    Sako A; Gu Y; Masui Y; Yoshimura K; Yanai H; Ohmagari N
    PLoS One; 2023; 18(10):e0291673. PubMed ID: 37792686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary Incontinence Medications: Patient-Initiated Concerns in Primary Care.
    Neuner J; Schmitt E; Winn A; Davidson E; O'Connor RC; Marowski S; Luebke M; Balza J; Attewell M; Flynn KE
    Urogynecology (Phila); 2024 Jun; ():. PubMed ID: 38954604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic Impact of Bladder Cancer in the USA.
    Clark O; Sarmento T; Eccleston A; Brinkmann J; Picoli R; Daliparthi V; Voss J; Chandrasekar S; Thompson A; Chang J
    Pharmacoecon Open; 2024 Aug; ():. PubMed ID: 39154309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.